Supplements

Herbal products including Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera show clinical promise for mental health symptoms in children and adolescents.

A systematic review of 29 clinical trials identified 11 herbal products with clinical promise for pediatric mental health conditions including ADHD, anxiety, depression, nervous agitation, restlessness, and sleep disturbances. The review highlights both potential benefits and current limitations, emphasizing the need for standardized preparations and clinical oversight.

Last updated: Aug 16, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Medicinal Plants for Child Mental Health: Clinical Insights, Active Compounds, and Perspectives for Rational Use.

observational

Rigillo G, Blom JMC, Cocchi A, Martinucci V, Favaro F, Baini G, Cappellucci G, Tascedda F, Biagi M ยท Children (Basel, Switzerland) (2025)

Participants: N/A
Duration: N/A
Intervention: Herbal medicines and botanical food supplements (Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, Withania somnifera)
Outcome: Behavioral or cognitive outcomes related to mental health symptoms (ADHD, anxiety, depression, nervous agitation, restlessness, sleep disturbances)
Effect Size: N/A
Population: Children and adolescents with mental health symptoms (including pathological conditions and borderline symptoms)

Result:

Mechanism Graph

Herbal compounds interact with multiple molecular targets
โ†“
Bioinformatic predictions reveal polypharmacological activity
โ†“
Pathways involve neuroinflammatory, neuroprotective, and neurotransmitter-related mechanisms
โ†“
Result: Potential therapeutic effects on pediatric mental health symptoms

Limitations

  • โš Limited number of clinical trials (29 total) with varying quality and design
  • โš Lack of specific dosing, safety, and integrative care strategy data for pediatric populations

Frequently Asked Questions

Which herbal products showed clinical promise for child mental health?โ–ผ

Eleven herbal products were identified: Bacopa monnieri, Crocus sativus, Ginkgo biloba, Hypericum perforatum, Lavandula angustifolia, Melissa officinalis, Panax ginseng, Passiflora incarnata, Pinus pinaster, Valeriana officinalis, and Withania somnifera.

What conditions were studied in the clinical trials?โ–ผ

The trials covered pathological conditions like ADHD, anxiety, and depression, as well as borderline symptoms such as nervous agitation, restlessness, and sleep disturbances.

What are the main limitations of using herbal products for pediatric mental health?โ–ผ

The review highlights limited clinical trial evidence, lack of standardized dosing and safety data for children, and the need for clinical oversight and further research.

What mechanisms might explain the effects of these herbal products?โ–ผ

Bioinformatic analyses suggest polypharmacological activity involving neuroinflammatory, neuroprotective, and neurotransmitter-related pathways.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Rigillo G, Blom JMC, Cocchi A, Martinucci V, Favaro F, Baini G, Cappellucci G, Tascedda F, Biagi M. "Medicinal Plants for Child Mental Health: Clinical Insights, Active Compounds, and Perspectives for Rational Use.." Children (Basel, Switzerland), 2025. PMID: 41007011 DOI: 10.3390/children12091142
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.